Evidence map›Paper›PMID 41059651›Full record

ArticleJournal of the International AIDS Society2025

Harnessing digital health data for person-centred HIV prevention monitoring: a survey of national health information systems.

Shona Dalal, Bradley Mathers, Dominik Stelzle, Lilly M Nyagah, Francis Agbo, Dennis Annang, Saiprasad Prabhakar Bhavsar, Stone Mbiriyawanda, Bongiwe Mhlanga, Tshepo Molapo and 17 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Person-centred HIV prevention in an era of innovation and uncertainties.Journal of the International AIDS Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Shona DalalGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-1684-7452
Bradley MathersKirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Dominik StelzleGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Lilly M NyagahMinistry of Health, National AIDS, STI and Viral Hepatitis Control Program, Nairobi, Kenya.
Francis AgboNational Agency for the Control of HIV/AIDS, Abuja, Nigeria.
Dennis AnnangGhana AIDS Commission, Accra, Ghana.
Saiprasad Prabhakar BhavsarMinistry of Health and Family Welfare, New Delhi, India.
Stone MbiriyawandaMinistry of Health, Lilongwe, Malawi.
Bongiwe MhlangaMinistry of Health, Mbabane, Eswatini.
Tshepo MolapoDepartment of Health, Johannesburg, South Africa.
Lowrence MoroMinistry of Health, Juba, South Sudan.
Peter MudiopeMinistry of Health, Kampala, Uganda.
Linea NgwaliMinistry of Health, Windhoek, Namibia.
Mwiche Siame NyirendaMinistry of Health, Lusaka, Zambia.
Isabel SathaneMinistry of Health, Maputo, Mozambique.
Rajatashuvra AdhikaryWorld Health Organization, India Country Office, New Delhi, India.
Monica Alonso GonzalezPan-American Health Organization, Washington, DC, USA.
Polin ChanWorld Health Organization Regional Office for South-East Asia, New Delhi, India.
Annette GerritsenThe Global Fund, Geneva, Switzerland.
Kiyohiko IzumiWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
Giorgi KuchukhidzeWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Antons MozalevskisGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Georges PerrinWorld Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo.
Ahmed S AlaamaWorld Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Madidimalo TebogoWorld Health Organization, Gaborone, Botswana.
Annette VersterGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Daniel Low-BeerGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionMeasuring HIV prevention impact is challenging because prevention is started and stopped as needed, and individual-level data availability has been suboptimal or not collected. WHO's 2022 Consolidated guidelines on person-centred HIV strategic information aim to bridge this gap by recommending a minimum dataset for HIV prevention monitoring.

methodsWe surveyed the availability of 42 HIV prevention data elements collected on an individual from WHO's recommended minimum dataset in 21 countries' national health information systems during a Prevention Outcome Monitoring Workshop held in September 2024 in Gaborone, Botswana. Over 150 participants representing ministries of health and programme implementers from 21 countries in Africa and Asia, as well as representatives from global organizations, attended. National HIV prevention managers completed the survey covering: registration (client demographics, use of unique identification, key population status), HIV testing, HIV prevention and vertical transmission. Data element availability determined which prevention indicators each country could calculate. Additionally, we describe global data on the use of unique identification for key populations.

resultsOf the 21 attending countries, 18 completed the survey. Fifteen countries (83%) used unique identification in their national health information systems. All 18 countries collected HIV testing data elements, while 14-18 countries (78-100%) collected those for vertical transmission. However, prevention data availability varied widely. Different data elements on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) were collected by 13-17 (72-94%) countries, condoms by 15 (83%) and voluntary medical male circumcision by 11 (61%) countries. Data elements on harm reduction were available in 4-6 countries among 8-10 countries providing services. While all countries could calculate HIV testing indicators, around 90% could for vertical transmission, 50-94% for PrEP/PEP and 40-75% for harm reduction. Only two countries could calculate linkage to prevention, which incorporates all prevention interventions. Kenya was the only country that collected all recommended person-centred data elements. Overall, up to 37 of 105 reporting countries had a nationally harmonized personal unique identification method for key populations.

conclusionsData building blocks for HIV prevention exist in most national health information systems. Aligning these systems with global standards offers potential to further strengthen person-centred HIV prevention monitoring.

Indexed as

Health Information SystemsHIV InfectionsAfricaBotswanaDigital HealthFemaleHumansInfectious Disease Transmission, VerticalMaleSurveys and Questionnairesdatahealth information systemsHIVpreventionsurveillancetesting

Identifiers

PMID41059651
PMCPMC12505196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.